The United Laboratories International Holdings Limited provided consolidated earnings guidance for the year ended 31 December 2021. The board of directors the Company informed the shareholders of the Company and the potential investors that, based on the unaudited consolidated management accounts of the Company for the year ended 31 December 2021 prepared in accordance with Hong Kong Financial Reporting Standards, the Group is expected to record a profit of approximately RMB 980,000,000 for the year 2021, while the profit for the year 2020 was approximately RMB 701,000,000. The increase in profit during the year is mainly contributed from (i) gross profit increase of approximately RMB 400,000,000 as increased turnover for three business segments simultaneously and continue increase in market prices of intermediate products; (ii) there is no loss on fair value change of embedded derivative components of convertible bonds during current year; and (iii) decrease in finance costs of approximately RMB 120,000,000 due to decrease in borrowings and lower loan interest rates, and all interest bearing convertible bonds have been converted into shares in 2020.